Details for 2013730364

Up to date per 01.04.2026

Actions

Title / Product Name

ZUR BEHANDLUNG VON (UNTER ANDEREM) DER ALZHEIMERSCHEN KRANKHEIT GEEIGNETE SUBSTITUIERTE DERIVATE DES 3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRAZIN-1,6-DIONS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013730364

EP Publication Number

2850083

E-Number

794681

Language

PCT Number

IB13054014

Publication Date

25.03.2015 A

27.04.2016 B1

Registration Date

27.04.2016

AT Publication Date

15.05.2016

Application Date

16.05.2013

Registration Number

Priorities

16.05.2012

12168186

06.12.2012

12195875

13.12.2012

12197010

14.03.2013

13159178

IPC

C07D 471/04 20060101AFI20131206BHEP

Maximum Duration of Protection

16.05.2033

Owner

Janssen Pharmaceuticals, Inc.1125 Trenton-Harbourton Road Titusville, NJ 08560US

Cellzome Limited980 Great West Road Brentford, Middlesex TW8 9GSGB

Representative

No representatives present

Inventor

ROMBOUTS, Frederik, Jan, Ritac/o Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE

TRABANCO-SUÁREZ, Andrés, Avelinoc/o Janssen-Cilag S.A. Calle Jarama 75 Poligono Industrial E-45007 ToledoES

GIJSEN, Henricus, Jacobus, Mariac/o Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE

MACDONALD, Gregor, Jamesc/o Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE

BISCHOFF, François Paulc/o Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE

ALONSO-de DIEGO, Sergio-Alvarc/o Janssen-Cilag S.A. Calle Jarama 75 Poligono Industrial E-45007 ToledoES

VELTER, Adriana, Ingridc/o Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 BeerseBE

VAN ROOSBROECK, Yves, Emiel, Mariac/o Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 BeerseBE